Details for Patent: 6,703,396

✉ Email this page to a colleague

Summary for Patent: 6,703,396

Title:	Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
Abstract:	A process for the resolution of a racemic mixture of nucleoside enantiomers that includes the step of exposing the racemic mixture to an enzyme that preferentially catalyzes a reaction in one of the enantiomers. The nucleoside enantiomer (-)-2-hydroxymethyl-5-(5-flurocytosin-1-yl)-1,3-oxathiolane is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner.
Inventor(s):	Liotta; Dennis C. (Stone Mountain, GA), Schinazi; Raymond F. (Decatur, GA), Choi; Woo-Baeg (North Brunswick, NJ)
Assignee:	Emory University (Atlanta, GA)
Application Number:	08/402,730
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,703,396
Patent Claim Types: see list of patent claims	Compound; Composition; Use; Dosage form;

Drugs Protected by US Patent 6,703,396

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,703,396

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	9104741	Mar 06, 1991
United Kingdom	9109505	May 02, 1991

International Family Members for US Patent 6,703,396

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0513200	⤷ Sign Up	91073	Luxembourg	⤷ Sign Up
European Patent Office	0513200	⤷ Sign Up	300148	Netherlands	⤷ Sign Up
European Patent Office	0513200	⤷ Sign Up	SPC/GB04/016	United Kingdom	⤷ Sign Up
European Patent Office	0513200	⤷ Sign Up	SZ 7/2004	Austria	⤷ Sign Up
European Patent Office	0513200	⤷ Sign Up	C00513200/01	Switzerland	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.